Latest News in the pharma Industry

Top Stories

India in Talks with EU to Ease Restrictions on Ayurveda Drugs

India in Talks with EU to Ease Restrictions on Ayurveda Drugs

17 May 2011

According to the ban came into force from May 1, a company needs to demonstrate its efficacy and safety through traditional use for at least 30 years of which 15 years should be within EU. The new guideline mandates registration of a herbal medicine.

Read more 
Astellas & BioFocus Ink Target Discovery Deal

Astellas & BioFocus Ink Target Discovery Deal

16 May 2011

BioFocus has signed a collaboration agreement with Tokyo-based Astellas Pharma focused on discovering novel targets in the field of CNS disorders.

Read more 
Swiss Approves Novartis’ Votubia Tablets for SEGA

Swiss Approves Novartis’ Votubia Tablets for SEGA

12 May 2011

The drug is the first to be approved in Switzerland for treating subependymal giant cell astrocytoma (SEGA).

Read more 
EMD Millipore Opens Biopharmaceutical Technical Center in Shanghai

EMD Millipore Opens Biopharmaceutical Technical Center in Shanghai

12 May 2011

The facility will provide support, training and validation services to EMD Millipore’s biopharma customers with operations in China.

Read more 
ICON & Boston Research Institute Form Alliance

ICON & Boston Research Institute Form Alliance

12 May 2011

The alliance will combine BCRI’s leadership in clinical strategy, study planning and academic relationships with ICON’s experience in the execution of global clinical trials.

Read more 
Onyx Scientific Wins Phase I API Contract

Onyx Scientific Wins Phase I API Contract

11 May 2011

Cancer Research UK has selected the UK-based API manufacturer to develop the chemistry and perform the GMP synthesis of the API for use in a Phase 1 clinical trial.

Read more 
Immunologix & DavosPharma Form Marketing Alliance

Immunologix & DavosPharma Form Marketing Alliance

11 May 2011

The partnership allows both parties to offer their clients a platform to 100% human monoclonal antibody ready for clinical trials.

Read more 
Sanofi-Aventis Changes Name to Sanofi

Sanofi-Aventis Changes Name to Sanofi

11 May 2011

French pharmaceutical group Sanofi-Aventis has abandoned its double-barreled name it acquired along with Aventis in 2004.

Read more 
Alkermes to Merge With Elan Drug Technologies

Alkermes to Merge With Elan Drug Technologies

10 May 2011

Alkermes Inc. said Monday it will merge with Elan Drug Technologies in a cash-and-stock deal valued at $960 million.

Read more 
J&J Files New Concerta Lawsuit Against Impax Labs

J&J Files New Concerta Lawsuit Against Impax Labs

10 May 2011

Impax said the lawsuit alleges its generic violates patents belonging to Alza supporting Concerta tablets of 18 milligrams, 27 milligrams and 36 milligrams.

Read more 
Quotient Clinical Completes Expansion in UK

Quotient Clinical Completes Expansion in UK

9 May 2011

The new facilities have been inspected and approved for use by the UK regulatory authority and have been awarded Supplementary Accreditation.

Read more 
Bristol-Myers Squibb Recalls Coumadin Tablets

Bristol-Myers Squibb Recalls Coumadin Tablets

9 May 2011

Bristol-Myers Squibb has initiated a voluntary recall of Coumadin crystalline 5mg tablets used to treat or prevent blood clots.

Read more